Anti DilutionCalculation English

Embed Size (px)

Citation preview

  • 8/10/2019 Anti DilutionCalculation English

    1/12

  • 8/10/2019 Anti DilutionCalculation English

    2/12

    INTRODUCTION

    You raise series A venture capita ast year w en your company was va ue at 30mi ion. Now, you nee toraise the series B, but the investors tell you that your company is only worth $20 million. What does this mean to

    you? And, what is the effect of the "Anti-dilition Provision" in the series A investors' Term Sheet?

    This workbook will calculate how much common shareholders will be diluted in the series B venture financing

    (preferred stock) which is priced lower than the first round venture financing.

    You can see t e i ution w ere t e series A inancing provi es or 2 scenarios: Simp e Scenario an Norma

    Scenario. In the aimple scenario, you know the purchase price and shares number for Series B investor. But this

    is not the normal scenario, where you only know the pre-money valuation and the investment amount for the

    Series B investor. In each scenario, there are there situations:

    1 - no adjustment to the conversion price

    2 - partial adjustment to the conversion price: (Broad-based weighted average & Narrow-based weighted

    3 - full adjustment of the conversion price: (Full ratched)

    The workbook includes 3 worksheets:

    Introduction

    Assumptions and Results

    Simple Scenario (Calculation Details)

    Normal Scenario (Calculation Details)

    Just fill in the highlighted assumptions on the worksheet -- 'Assumptions and Results'.

    Drafted by: Sam GUI, Dec. 2007

    Personal Blog: Venture Capital Consultant

    http://naixiaobao.spaces.live.com/http://naixiaobao.spaces.live.com/
  • 8/10/2019 Anti DilutionCalculation English

    3/12

  • 8/10/2019 Anti DilutionCalculation English

    4/12

    Simple ScenarioAssumptions

    Founder's Common share 40,000,000Series A Preferred Purchase Price $1.00Series A Preferred share 10,000,000Series B Preferred Purchase Price $0.50Series B Preferred share 5,000,000

    Company Ownership

    Broad based

    Common share 80.00% 72.73% 72.10%

    Series A investor 20.00% 18.18% 18.88%Series B investor 0.00% 9.09% 9.01%

    Valuation, Purchase Price & Conversion Price

    Broad based

    Series A conversion price $1.00 $0.95Series B purchase price $0.50 $0.50Series A post-money valuation $50,000,000 $50,000,000Series B pre-money valuation $25,000,000 $25,238,095Series A as-converted common shares 10,000,000 10,476,190Series B preferred shares 5,000,000 5,000,000Series B investment 2,500,000 2,500,000

    Normal ScenarioAssumptionsFounder's Common share 8,000,000Series A Investment $2,000,000Series A Preferred share % 20.00%Series B Investment $8,000,000Series B Pre-money Valuation $8,000,000

    Company Ownership

    Broad based

    Common share 80.00% 40.00% 39.02%

    Series A investor 20.00% 10.00% 10.98%Series B investor 0.00% 50.00% 50.00%

    Valuation, Purchase Price & Conversion Price

    Broad based

    Series A conversion price $1.00 $0.8889Series B purchase price $0.80 $0.7805Series A post-money valuation $10,000,000 $10,000,000

    Before

    Series B

    Non

    anti-dilution

    Weighte

    Non

    anti-dilution

    Weighte

    Before

    Series B

    Non

    anti-dilution

    Weighte

    Non

    anti-dilution

    Weighte

  • 8/10/2019 Anti DilutionCalculation English

    5/12

    Series B pre-money valuation $8,000,000 $8,000,000Series A as-converted common shares 2,000,000 2,250,000Series B preferred shares 10,000,000 10,250,000Series B investment 8,000,000 8,000,000

  • 8/10/2019 Anti DilutionCalculation English

    6/12

    Narrow based

    70.18% 61.54%

    21.05% 30.77%8.77% 7.69%

    Narrow based

    $0.83 $0.50

    $0.50 $0.50

    $50,000,000 $50,000,000$26,000,000 $30,000,000

    12,000,000 20,000,0005,000,000 5,000,000

    2,500,000 2,500,000

    Narrow based

    38.10% 37.50%

    11.90% 12.50%50.00% 50.00%

    Narrow based

    $0.8000 $0.75

    $0.7619 $0.75

    $10,000,000 $10,000,000

    Average Full Ratchet

    anti-dilution

    Average Full Ratchet

    anti-dilution

    Full Ratchet

    anti-dilution

    Average Full Ratchet

    anti-dilution

    Average

  • 8/10/2019 Anti DilutionCalculation English

    7/12

    $8,000,000 $8,000,0002,500,000 2,666,667

    10,500,000 10,666,6678,000,000 8,000,000

  • 8/10/2019 Anti DilutionCalculation English

    8/12

    AssumptionsFS Founder's Common share 40,000,000

    OP Series A Preferred Purchase Price $1.00

    AS Series A Preferred share 10,000,000NP Series B Preferred Purchase Price $0.50BS Series B Preferred share 5,000,000

    AI Series A Investment 10,000,000BI Series B Investment 2,500,000

    Before Series B Financing

    Common share 40,000,000Series A Conversion Price $1.00Series A Common share on As-converted Base 10,000,000 Total Fully Diluted Shares 50,000,000Series A Post-money Valuation 50,000,000

    Non anti-dilution

    Common share 40,000,000Series A Conversion Price $1.00Series A Common share on As-converted Base 10,000,000Series B Conversion Price $0.50Series B Common share on As-converted Base 5,000,000 Total Fully Diluted Shares 55,000,000Series B Post-money Valuation 27,500,000

    Broad based weighted average

    Common share 40,000,000

    WP Series A Conversion Price $0.95

    Series A Common share on As-converted Base 10,476,190Series B Conversion Price $0.50Series B Common share on As-converted Base 5,000,000 Total Fully Diluted Shares 55,476,190Series B Post-money Valuation 27,738,095

    Narrow based weighted average

    Common share 40,000,000

    WP Series A Conversion Price $0.83Series A Common share on As-converted Base 12,000,000Series B Conversion Price $0.50

    Series B Common share on As-converted Base 5,000,000 Total Fully Diluted Shares 57,000,000Series B Post-money Valuation 28,500,000

    Full Ratchet anti-dilution

    Common share 40,000,000

    FP Series A Conversion Price $0.50Series A Common share on As-converted Base 20,000,000Series B Conversion Price $0.50Series B Common share on As-converted Base 5,000,000 Total Fully Diluted Shares 65,000,000

    Calculation Details

  • 8/10/2019 Anti DilutionCalculation English

    9/12

    Series B Post-money Valuation 32,500,000

    Loss of value between Series A and Series B

    Series A post-money valuation 50,000,000

    Series B pre-money valuation 25,000,000Loss in value -25,000,000

    Series B post-money valuation 27,500,000Founder's value after Series B 20,000,000Series A investor's value after Series B 5,000,000

    Shared between:

    Founder's value lost -20,000,000% 80.00%

    Series A investor's value lost -5,000,000% 20.00%

    Non

    anti-dilution

  • 8/10/2019 Anti DilutionCalculation English

    10/12

  • 8/10/2019 Anti DilutionCalculation English

    11/12

    Broad based Narrow based

    50,000,000 50,000,000 50,000,000

    25,238,095 26,000,000 30,000,000-24,761,905 -24,000,000 -20,000,000

    27,738,095 28,500,000 32,500,00020,000,000 20,000,000 20,000,0005,238,095 6,000,000 10,000,000

    -20,000,000 -20,000,000 -20,000,00080.77% 83.33% 100.00%

    -4,761,905 -4,000,000 019.23% 16.67% 0.00%

    Weighted Average Full Ratchet

    anti-dilution

  • 8/10/2019 Anti DilutionCalculation English

    12/12

    % Ownership

    Before Series B Financing

    Founder's Share 8,000,000 80.00%Series A Conversion Price $1.00Series A Common share on As-converted Base 2,000,000 20.00% Total Fully Diluted Shares 10,000,000 100.00%

    Non anti-dilution

    Common share 8,000,000 40.00%Series A Conversion Price $1.00Series A Common share on As-converted Base 2,000,000 10.00% Total Fully Diluted Shares Before Series B 10,000,000Series B Pre-money Valuation $8,000,000Series B Investment $8,000,000Series B shares 10,000,000 50.00%

    NP Series B Purchase Price $0.80 Total Fully Diluted Shares 20,000,000 100.00%

    Broad based weighted average

    Common share 8,000,000 39.02%WP Series A Conversion Price $0.8889

    Series A Common share on As-converted Base 2,250,000 10.98% Total Fully Diluted Shares Before Series B 10,250,000Series B Pre-money Valuation $8,000,000Series B Investment $8,000,000Series B shares 10,250,000 50.00%

    NP Series B Purchase Price $0.7805 Total Fully Diluted Shares 20,500,000 100.00%

    Narrow based weighted average

    Common share 8,000,000 38.10%WP Series A Conversion Price $0.8000

    Series A Common share on As-converted Base 2,500,000 11.90% Total Fully Diluted Shares Before Series B 10,500,000Series B Pre-money Valuation $8,000,000Series B Investment $8,000,000Series B shares 10,500,000 50.00%

    NP Series B Purchase Price $0.7619 Total Fully Diluted Shares 21,000,000 100.00%

    Full Ratchet anti-dilution

    Common share 8,000,000 37.50%FP Series A Conversion Price $0.75

    Series A Common share on As-converted Base 2,666,667 12.50% Total Fully Diluted Shares Before Series B 10,666,667Series B Pre-money Valuation $8,000,000Series B Investment $8,000,000Series B shares 10,666,667 50.00%

    NP Series B Purchase Price $0.75 Total Fully Diluted Shares 21,333,333 100.00%

    Loss of value between Series A and Series B

    Broad based Narrow based

    Series A post-money valuation 10,000,000 10,000,000 10,000,000 10,000,000Series B pre-money valuation 8,000,000 8,000,000 8,000,000 8,000,000Loss in value -2,000,000 -2,000,000 -2,000,000 -2,000,000

    Series B post-money valuation 16,000,000 16,000,000 16,000,000 16,000,000Founder's value after Series B 6,400,000 6,243,902 6,095,238 6,000,000Series A investor's value after Series B 1,600,000 1,756,098 1,904,762 2,000,000

    Shared between:

    Founder's value lost -1,600,000 -1,756,098 -1,904,762 -2,000,000% 80.00% 87.80% 95.24% 100.00%

    Series A investor's value lost -400,000 -243,902 -95,238 0% 20.00% 12.20% 4.76% 0.00%

    Non

    anti-dilution

    Weighted Average Full Ratchet

    anti-dilution

    FS

    AINVNPFP

    BIAINPFSBINV

    BIAINPFS

    BINVNP

    NP

    BI

    NP

    AIFS

    BINVNP

    NPFP

    Full

    )(

    2)(

    )(

    )(

    )()(

    AIFSOPAIBIAIFSOPOPFS

    OPBIAIBIAIFSOPOPNVBP

    NP

    BI

    OPBINPAIFSNPOP

    BIAIFSOPNPOP

    AIFS

    BINV

    NP

    BI

    WP

    AIFS

    BINVNP

    OPBINPAIFSNPOP

    BIAIFSOPNPOP

    NP

    BI

    OP

    AIFS

    BIOP

    AIFSOP

    WP

    BW

    2)(

    )(

    )(

    )(

    AIBIAIOPFS

    OPBIAIBIAIOPNVBP

    NP

    BI

    OPBINPAI

    BIAINPOP

    AIFS

    BINV

    NP

    BI

    WP

    AIFS

    BINVNP

    OPBINPAI

    BIAINPOP

    NP

    BI

    OP

    AI

    BIOP

    AIOP

    WP

    NW